Pia Žižek

Pia Žižek

Auto-generated profile, based on publicly available information

Pia Žižek

National Institute of Biology, Department of Genetic Toxicology and Cancer Biology, Ljubljana 1000, Slovenia; Jožef Stefan International Postgraduate School, Ljubljana 1000, Slovenia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2025 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
NFNina Franko
Nina Franko
TMTijana Markovic
Tijana Markovic
PŽPia Žižek
Pia Žižek
AKAnja Kodila
Anja Kodila
IRIrena Mlinarič Raščan
Irena Mlinarič Raščan
MDMarija Sollner Dolenc
Marija Sollner Dolenc
This study investigates the immunomodulatory effects of BPA substitutes using in silico and in vitro approaches. A comprehensive in silico screening with Endocrine Disruptome of BPA and its 25 substitutes revealed that BPG, BPS-MAE, BPS-MPE, BPPH and PF201 have the highest potential to bind nuclear receptors. Based on the in silico ranking, 12 compounds were selected and tested in vitro to investigate their effects on THP-1 derived macrophages, Jurkat T cells and LCLs. The metabolic activity tests showed that BPA has IC50 values of 99-182 µM, while the values for BPG, BPPH and BPP are 5-10 times lower. Comparison of the IC50 values with the logP of the tested compounds showed that the BPA analogues affect cell viability in proportion to their lipophilicity (R2 = 0.9185). The results of the cytokine release assays showed that the BPA substitutes generally stimulated the proinflammatory response in THP-1 macrophages in a statistically significant manner when exposed to the environmentally relevant concentrations and suppressed it in the micromolar range in all cell lines tested. Further analysis using RamosBlue reporter cells indicated that BPAP, BPG, BPP and BPPH alter the NF-κB/AP-1 signalling pathway. Moreover, BPAP, BPG, BPP, BPPH, BPS-MAE, BPS-MPE, BTUM and PF201 were predicted in silico to be TLR4-MyD88 inhibitors. The overall results of this study identify BPG, BPP, BPPH, BPZ and TCBPA as BPA analogues with the highest immunomodulatory potential. In addition, the immunomodulatory potential of the BPA alternatives Pergafast201 and BTUM was confirmed in vitro for the first time. This study emphasises the need for cautious evaluation of BPA substitutes due to their potential immunomodulatory effect, which could significantly affect public health.

14 December 2021 in Acta medico-historica Adriatica
Verified
Journal Article
Closed access
PDF file
PŽPia Žižek
Pia Žižek
The Second World War created a caesura in various spheres of life, including medical care. Many doctors and nurses in Slovenia joined the Partisan movement and helped organise medical care. The first activities were undertaken in 1942, followed a year later by the development of the first rudimentary, clandestine partisan medical stations acting as hospitals. Nearly 15 000 patients with injuries and illnesses were treated in such partisan medical facilities. The staff included 244 doctors and dentists, 260 medical students, 38 nurses and more than 3 000 ad hoc trained medics. This article presents the “Celje” partisan hospital from the Upper Savinja Valley, focusing on the testimonies of Partisan doctors and other witnesses who provided first-hand accounts about everyday life in this and other Partisan medical facilities. The main source of information was the notes of surgeon Dr Robert Kukovec, which date from the final year of the war. Dr Kukovec was among the few individuals who left behind a written account of the wartime events they had witnessed, offering an insight into the tragedy of war. His account also depicts many sombre moments but also rare bright ones, in particular the yearning for the freedom that destiny prevented Dr Kukovec from experiencing, given that he was killed less than a month before the end of the war.

30 October 2025 in bioRxiv
Verified
Preprint
Open access
AHAnamarija Habič
Anamarija Habič
TMTina Kolenc Milavec
Tina Kolenc Milavec
PŽPia Žižek
Pia Žižek
ŠKŠpela Kladnik
Špela Kladnik
BMBernarda Majc
Bernarda Majc
Barbara BreznikBarbara Breznik
Barbara Breznik
Glioblastoma (GB) is an aggressive primary brain cancer with poor patient prognosis. Natural killer (NK) cells can recognise and eliminate a range of malignant cells, including GB stem cells, which drive GB recurrence. NK cell-based immunotherapy has emerged as a promising approach for GB treatment, but a better understanding of the complex crosstalk between GB and NK cells is needed, particularly within the immunosuppressive GB tumour microenvironment. In this study, we established a reproducible protocol for the production and dynamic culture of uniformly sized GB spheroids using the Celvivo Clinostar system. Our spheroids recapitulated the heterogeneous structure of GB and expressed ligands for NK cell receptors at levels distinct from those observed in corresponding GB cell lines in standard culture, implicating altered sensitivity of GB cells to NK cells in dynamic 3D cultures. GB-NK cell crosstalk was GB cell type dependent and the ability of NK cells to infiltrate GB did not necessarily correlate with their cytotoxicity against GB cells. Spheroids derived from differentiated GB cells secreted higher levels of immunomodulatory cytokines compared to spheroids from GB stem-like cells, and a prominent increase in the secretion of immune-attracting factors was observed in their co-cultures with NK cells. Finally, the CD155-DNAM1/TIGIT axis was indicated as an important regulator of NK cell cytotoxicity against GB stem-like cells. Collectively, our results highlight important factors in GB-NK cell communication and provide a groundwork for further targeted research as well as therapeutic evaluation of NK cell-based approaches in the established dynamic 3D cultures.

4 August 2026 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MNMetka Novak
Metka Novak
BMBernarda Majc
Bernarda Majc
MVMarija Skoblar Vidmar
Marija Skoblar Vidmar
ŠKŠpela Kladnik
Špela Kladnik
TMTina Kolenc Milavec
Tina Kolenc Milavec
Barbara BreznikBarbara Breznik
Barbara Breznik
Glioblastoma (GBM) remains one of the most lethal human malignancies, yet extraneural metastases are exceptionally rare and poorly understood. Standard treatment-surgical resection followed by chemoradiotherapy-offers only modest survival benefits, and therapeutic options for metastatic GBM are limited. Here, we describe a rare clinical case of metastatic GBM and provide comprehensive molecular characterization alongside a potential targeted treatment strategy. The tumor exhibited several molecular features associated with aggressive behavior, including alterations in the tumor suppressor genes NF1, TP53, PTEN, and RB1, a mesenchymal DNA‑methylation subclass, and activation of the MAPK signaling pathway. To functionally evaluate therapeutic vulnerabilities, we developed tumor models using patient‑derived GBM cells and their assembloids with cerebral organoids that recapitulate patient‑specific tumor biology and the human brain microenvironment. We identified the MEK inhibitor trametinib as a promising candidate capable of selectively reducing viability and invasion of highly aggressive, stem‑like GBM cells within our personalized patient-derived tumor avatars. This work highlights the proof-of-concept evidence that MEK pathway inhibition may represent a potential therapeutic vulnerability to counteract rapid tumor spread and improve responsiveness to temzolomide in this individual metastatic GBM case. Study underscores the need for continued research to advance targeted, multi‑modal therapeutic approaches for GBM.